30.06.2014 Views

John M. S. Bartlett.pdf - Bio-Nica.info

John M. S. Bartlett.pdf - Bio-Nica.info

John M. S. Bartlett.pdf - Bio-Nica.info

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Serial Analysis of Gene Expression 271<br />

40<br />

Serial Analysis of Gene Expression<br />

Karin A. Oien<br />

1. Introduction<br />

Serial analysis of gene expression (SAGE ) is a patented, large-scale mRNAprofiling<br />

technology that produces comprehensive, quantitative, and reproducible<br />

gene expression profiles (originally described in refs. 1 and 2). Unlike the alternative<br />

technologies of differential display and subtractive hybridization, SAGE produces a<br />

full catalog of all transcripts, not only differentially expressed genes, and unlike smaller<br />

arrays, SAGE needs no assumptions about the genes that are likely to be expressed,<br />

thus allowing the identification of novel genes (are among many excellent reviews, see<br />

refs. 3–5). SAGE is based on generating clones of concatenated (linked) short sequence<br />

tags derived from mRNA from the target cells or tissue (Fig. 1).<br />

Each tag is 9- or 10-bp long and represents one mRNA and each clone insert contains<br />

up to 40 tags joined serially. Therefore, sequencing of multiple concatenates describes<br />

the pattern and abundance of mRNA, with an improvement in efficiency of up to<br />

40-fold compared with conventional analysis of expressed sequence tags. The mRNA<br />

transcript corresponding to the short SAGE tag is identified from genetic databases<br />

using appropriate software.<br />

The SAGE method was developed in 1995 by Velculescu et al. (1) of the Kinzler and<br />

Vogelstein laboratory at <strong>John</strong>s Hopkins University, from where the SAGE protocol,<br />

software, and updates are available to academic investigators for noncommercial use<br />

via http://www.sagenet.org/sage_protocol.htm. For commercial purposes, the user<br />

should contact Genzyme Corporation, who own and license the SAGE technology.<br />

This and other useful web sites are listed in Table 1. Since the first report of SAGE,<br />

many technical modifications have been described. Some enable the use of smaller<br />

amounts of starting material (3,6–10), whereas others have improved the efficiency<br />

of intermediary SAGE reactions (11–14). Invitrogen has also released a kit called<br />

I-SAGE , which provides all of the numerous reagents required in a high-quality<br />

form.<br />

The <strong>John</strong>s Hopkins protocol is 27 pages long, and Invitrogen’s online I-SAGE <br />

instructions contain 73 pages. This is because SAGE involves many stages, each using<br />

well-established and relatively straightforward molecular biological techniques, but any<br />

of which can go wrong! This article thus provides concise instructions with an emphasis<br />

From: Methods in Molecular <strong>Bio</strong>logy, Vol. 226: PCR Protocols, Second Edition<br />

Edited by: J. M. S. <strong>Bartlett</strong> and D. Stirling © Humana Press Inc., Totowa, NJ<br />

271

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!